Regulatory · source year

2011 regulatory records

7 selected, source-linked regulatory records dated 2011. This is selective source coverage, not a complete timeline.

Dated records

7 selected records.

Peptide profiles

4 connected profiles.

Cited sources

7 distinct public records.

Cited chronology

Dated source records

All record types in 2011 →

October 2011

1 record

Peginesatide

Federal Register notice 2011-27327

The Federal Register published notice 2011-27327, attributed to FDA and its parent HHS department, on 2011-10-24. Its official title is “Oncologic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Peginesatide.

Source: Federal Register via GovInfo ↗

→

August 2011

1 record

June 2011

1 record

Leuprolide

Federal Register notice 2011-14164

The Federal Register published notice 2011-14164, attributed to FDA and its parent HHS department, on 2011-06-08. Its official title is “Bristol-Myers Squibb Co. et al.; Withdrawal of Approval of 70 New Drug Applications and 97 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide.

Source: Federal Register via GovInfo ↗

→

May 2011

3 records

Icatibant

Federal Register notice 2011-12543

The Federal Register published notice 2011-12543, attributed to FDA and its parent HHS department, on 2011-05-23. Its official title is “Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Icatibant.

Source: Federal Register via GovInfo ↗

→

February 2011

1 record